Tonix Pharmaceuticals Holding Corp (NASDAQ: TNXP) Granted Orphan Drug Designation For...

0
Tonix Pharmaceuticals Holding Corp (NASDAQ: TNXP) has announced that the FDA has granted TNX-2900 an Orphan Drug Designation for Prader-Willi syndrome treatment. Tonix receives Orphan...
Banking stocks in focus

1606 Corp (CBDW) Expands into Artificial Intelligence with the Introduction of...

0
The realm of artificial intelligence has been present for a while, yet it garnered heightened attention with the launch of ChatGPT and...

1606 Corp ($CBDW) Preps for Global Launch of Cutting-Edge ChatCBD AI-Driven...

0
1606 Corp. (OTC Pink: CBDW) is gearing up for the global launch of ChatCBD, an advanced AI-driven online merchandising technology set to debut...

Popular News

MAKE IT MODERN

LATEST REVIEWS

MAKE IT MODERN

PERFORMANCE TRAINING

Celldex Therapeutics Inc. (NASDAQ:CLDX) Announce Encouraging CDX-0159 Study Results In Reducing Plasma Tryptase

0
Celldex Therapeutics Inc. (NASDAQ:CLDX) has announced results from its first phase, double-blind, randomized, placebo-controlled, dose-escalation KIT inhibitor CDX-0159 study in healthy subjects. CDX-0159 shows a...

Light Bio Inc and Gingko Bioworks Holdings Inc (NYSE: DNA) Announce Their Recent Partnership...

0
Light Bio Inc recently announced the execution of a partnership with Ginkgo Bioworks Holdings Inc (NYSE: DNA) to create specific cell assays for bioluminescence...

Denali Therapeutics Inc (NASDAQ:DNLI) Releases Major Update On Phase 1b Of Its RIPK1 Program

0
Denali Therapeutics Inc (NASDAQ:DNLI) provided an update on Phase 1b trial findings involving its RIPK1 small molecule inhibitor used to target ALS and Alzheimer’s...
Banking stocks in focus

1606 Corp (CBDW) Expands into Artificial Intelligence with the Introduction of CHATCBDW

0
The realm of artificial intelligence has been present for a while, yet it garnered heightened attention with the launch of ChatGPT and...

Affimed NV (NASDAQ:AFMD) Administers AFM13 Dose To The First Phase 1 Clinical Trial Patient

0
Affimed NV (NASDAQ:AFMD) kicked off October on a strong note particularly with the launch of its Phase 1 Clinical of its pipeline cancer therapy...

MAKE IT MODERN

POPULAR